Pharmacokinetics (PK), safety, and efficacy of [fam-] trastuzumab deruxtecan with OATP1B/CYP3A inhibitors in subjects with HER2-expressing advanced solid tumours

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; pp. v116 - v117
Main Authors Bang, Y.-J., Karayama, M., Takahashi, M., Watanabe, J., Minami, H., Yamamoto, N., Kinoshita, I., Lin, C.-C., Im, Y.-H., Fujiki, T., Achiwa, I., Kamiyama, E., Okuda, Y., Lee, C., Takahashi, S.
Format Journal Article
LanguageEnglish
Published 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdz242.025